NewLink Genetics to Participate in Upcoming Investor Conferences
Deutsche Bank 43rd AnnualHealth Care Conference onMay 9 at11:20 AM ET inBoston
Bank of America Merrill Lynch Global Healthcare Conference 2018 onMay 16 at5:15 PM PT (8:15PM ET ) inLas Vegas
A live webcast of both conference presentations will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events and Presentations.”
About NewLink Genetics Corporation
NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer.
Investor Contact:
Director of Investor Relations
515-598-2555
lmiller@linkp.com
Media Contact:
VP,
LaVoieHealthScience
617-374-8800, ext. 105
scorreia@lavoiehealthscience.com
Source: NewLink Genetics Corporation